Why Blood Sugar Matters for Long-Term Health

Most people have heard that high blood sugar is bad for health, but far fewer understand why blood sugar matters in mechanistic terms — what elevated glucose actually does to the body over months and years, and why the damage is so pervasive, progressive, and difficult to reverse once it begins. The answer lies in a set of interconnected biochemical processes through which glucose molecules directly damage proteins, blood vessel walls, nerves, and organ tissues throughout the body. These processes are silent — they produce no pain, no visible symptoms, and no warning signs until they have been running for years. Understanding them is the foundation for understanding why blood sugar management is not optional for people with diabetes or prediabetes, and why it matters even for people without a formal diagnosis who are in the upper-normal range.

How High Blood Sugar Damages the Body: The Core Mechanisms

The human body is exquisitely designed to handle glucose within a specific range. When blood glucose consistently exceeds that range — even by amounts that fall short of the official diabetes threshold — a cascade of damaging processes begins operating throughout the body simultaneously. The three main mechanisms are glycation, oxidative stress, and inflammation.

Glycation is the process by which glucose molecules attach to proteins and fats in the body without the assistance of enzymes — a random, chemistry-driven reaction that happens to any protein that is exposed to elevated glucose for extended periods. When glucose attaches to a protein, it alters that protein’s shape and function, creating what are called advanced glycation end products (AGEs). AGEs accumulate in collagen (the structural protein that maintains the integrity of blood vessel walls, skin, tendons, and cartilage), in kidney filtering structures, in the lens of the eye, and in nerve coverings. As AGEs accumulate, these structures become stiffer, less functional, and more vulnerable to damage. The A1C test that is used to diagnose and monitor diabetes is itself a measure of glycation — it measures the percentage of hemoglobin (the red blood cell protein that carries oxygen) that has had glucose attached to it, reflecting the average blood glucose level over the prior two to three months.

Oxidative stress occurs when high glucose levels overwhelm the body’s antioxidant defense systems, producing an excess of reactive oxygen species (free radicals) that damage cell membranes, DNA, and mitochondria. Mitochondria — the energy-producing structures inside cells — are particularly vulnerable, and their dysfunction impairs the cell’s ability to use oxygen and generate energy efficiently. Endothelial cells lining blood vessels are especially sensitive to oxidative stress, and their dysfunction is an early step in the development of atherosclerosis, the arterial plaque buildup that underlies heart attack and stroke.

Chronic low-grade inflammation is the third mechanism. Elevated blood glucose activates inflammatory signaling pathways, causing immune cells to release inflammatory cytokines that damage tissues over time. This inflammatory state impairs wound healing, reduces the effectiveness of the immune response against infections, and accelerates the cellular aging process in nearly every tissue type.

All three mechanisms operate simultaneously and reinforce each other, creating a compounding cycle of damage that explains why elevated blood sugar affects so many different systems at once and why the effects are cumulative — the longer blood sugar remains elevated, the more damage accumulates across the body.

Why Blood Sugar Matters for Heart Health

Cardiovascular disease is the leading cause of death among people with diabetes, claiming more lives than any direct complication of high blood sugar. The mechanisms linking blood sugar to heart disease are direct and well-established: glucose-driven glycation stiffens arterial walls, oxidative stress damages the endothelium (the inner lining of blood vessels), and chronic inflammation accelerates the formation and instability of arterial plaques.

Adults with diabetes face two to four times the risk of heart attack compared to adults with normal blood sugar — a risk elevation that persists even after accounting for blood pressure, cholesterol, and smoking. The risk begins rising not at the diabetes threshold, but in the prediabetes range: people with A1C values of 5.7 to 6.4 percent already show measurably elevated cardiovascular risk compared to those with A1C below 5.7 percent.

Beyond the direct effects on blood vessel walls, elevated blood sugar frequently co-occurs with the other major cardiovascular risk factors — high blood pressure, elevated triglycerides, low HDL cholesterol, and abdominal obesity — in what is called metabolic syndrome. This clustering multiplies cardiovascular risk beyond what any single factor would produce alone. Managing blood sugar is therefore inseparable from managing overall heart health.

The good news is that blood sugar improvements translate directly into reduced cardiovascular risk. Large trials such as the UKPDS (UK Prospective Diabetes Study) demonstrated that every 1 percentage point reduction in A1C was associated with a 21 percent reduction in any diabetes-related endpoint and a 14 percent reduction in heart attack risk. More recent trials of GLP-1 receptor agonist medications have shown that these drugs reduce major cardiovascular events (heart attack, stroke, and cardiovascular death) by 13 to 26 percent in people with Type 2 diabetes and high cardiovascular risk — an effect that goes beyond their blood sugar-lowering action.

Why Blood Sugar Matters for Kidney Health

The kidneys are among the organs most sensitive to sustained elevated blood glucose, and diabetic kidney disease (diabetic nephropathy) is the leading cause of end-stage renal disease requiring dialysis in the United States, accounting for approximately 44 percent of new cases each year. The kidneys filter approximately 200 liters of blood per day through millions of tiny capillary clusters called glomeruli. These delicate filtering units are damaged directly by elevated glucose and indirectly by the high blood pressure that so often accompanies diabetes.

Glycation of glomerular basement membranes — the structural proteins that form the filter — causes them to thicken and become leaky, allowing proteins (particularly albumin) to spill into the urine. Urinary albumin, measured in a simple urine test, is one of the earliest detectable markers of kidney damage in diabetes and can appear years before any measurable decline in kidney function. This is why annual urine albumin screening is a standard part of diabetes monitoring — early detection allows intervention (tight blood pressure control, medications that protect the kidney, and blood sugar improvement) before significant functional loss occurs.

Research has consistently shown that good blood sugar control dramatically reduces the risk of nephropathy progression. The DCCT trial in Type 1 diabetes found that intensive blood sugar control reduced the development of microalbuminuria (early kidney disease marker) by 39 percent compared to conventional management. The UKPDS found similar results in Type 2 diabetes. More recently, SGLT-2 inhibitors — a class of diabetes medications that work by causing the kidneys to excrete glucose in the urine — have been shown to reduce progression of kidney disease by 30 to 40 percent, independent of their blood sugar-lowering effect, and are now recommended for people with diabetes and kidney disease.

Why Blood Sugar Matters for Eye Health

The retina — the light-sensitive tissue at the back of the eye that converts visual information into nerve signals — is supplied by a dense network of extremely fine capillaries that are particularly vulnerable to glucose-induced damage. Diabetic retinopathy is the result: these tiny blood vessels leak, swell, and eventually close off, causing progressive retinal damage that can lead to permanent vision loss or blindness if untreated.

Retinopathy develops in stages. In nonproliferative retinopathy, the early stage, small vessels develop microaneurysms (tiny bulges), leak fluid and blood into the retinal layers, and may swell the central retina (diabetic macular edema), blurring central vision. In proliferative retinopathy — the advanced stage — new, fragile blood vessels grow across the retina in an attempt to compensate for the damaged ones. These new vessels are structurally abnormal and prone to rupturing, causing hemorrhage into the vitreous fluid of the eye and potentially leading to retinal detachment.

Diabetic retinopathy affects approximately one in three people with diabetes, and severe vision-threatening retinopathy affects approximately one in ten. It is the leading cause of new blindness among adults aged 20 to 74 in the United States. Yet it is also one of the most preventable complications: good blood sugar control reduces the risk of retinopathy development by 76 percent (DCCT), and laser treatment can effectively stabilize advanced disease before vision is permanently lost — but only if the disease is detected. Annual dilated eye exams are therefore a non-negotiable component of diabetes care.

Why Blood Sugar Matters for Nerve Health

Diabetic peripheral neuropathy — damage to the peripheral nerves, particularly those supplying the feet and lower legs — is the most common chronic complication of diabetes, affecting 60 to 70 percent of people with the condition at some point in their lives. It results from both the direct toxic effects of high glucose on nerve fibers and reduced blood supply to nerves from damaged small vessels.

The typical pattern begins with tingling, burning, or numbness starting in the toes and progressing upward. As neuropathy advances, protective sensation is lost: people can no longer feel pain, temperature, or pressure in their feet. This loss of protective sensation is the mechanism by which a small cut, blister, or pressure sore on the foot can escalate to a serious wound without being noticed, leading to infection, ulceration, and in severe cases, limb amputation. Approximately 60 percent of non-traumatic lower limb amputations in the United States occur in people with diabetes, the vast majority of which are preventable with adequate foot care and sensation preservation through good blood sugar control.

Autonomic neuropathy — damage to the nerves controlling involuntary body functions — can affect digestion (causing gastroparesis, a slowing of stomach emptying that makes blood sugar management unpredictable), heart rate variability, blood pressure regulation (causing orthostatic hypotension, or dizziness when standing), bladder function, and sexual function. These complications profoundly affect quality of life and are directly related to how long and how high blood sugar has been elevated.

The Cumulative Nature of Blood Sugar Damage

One of the most important — and most concerning — aspects of blood sugar-related organ damage is its cumulative, dose-dependent nature. The total amount of damage that develops over a lifetime is a function not just of how high blood sugar gets, but of how long it stays elevated. A modest elevation sustained for twenty years can cause more cumulative damage than a more severe elevation sustained for five years. This is why preventing or delaying diabetes, rather than waiting until it is diagnosed and then treating it, is such a significant health goal.

This cumulative nature also explains a phenomenon sometimes called “metabolic memory” or the “legacy effect”: people who achieve good blood sugar control early in the course of diabetes continue to have lower rates of complications years later, even if their blood sugar control subsequently deteriorates. Conversely, people who have poor blood sugar control for many years face ongoing complication risk even after improving their control — the prior damage creates a baseline of vulnerability that cannot be fully reversed. The practical implication is straightforward: the earlier in the course of blood sugar elevation that management is optimized, the more cumulative damage is prevented and the better the long-term outcome.

Understanding what blood sugar is, how it behaves after meals, and what target ranges look like provides the foundation for making sense of why controlling it matters so profoundly. For guidance on what happens to blood sugar after eating, see our guide on blood sugar after meals. For people already managing a diagnosis, tracking progress with the A1C test is the cornerstone of long-term complication prevention; see our detailed guide on the A1C test.

Blood Sugar and Brain Health

Emerging evidence has significantly strengthened the case that blood sugar management matters for cognitive health and dementia risk — an area that was not traditionally considered part of the diabetes complication picture but is now recognized as an important dimension of why blood sugar matters for long-term wellbeing.

People with Type 2 diabetes have approximately a 50 to 100 percent higher risk of developing dementia — both Alzheimer’s disease and vascular dementia — compared to people without diabetes. The mechanisms overlap with those causing other complications: glucose-driven oxidative stress and glycation affect brain cells and cerebral blood vessels, while insulin resistance in the brain impairs the clearance of amyloid proteins (the plaques associated with Alzheimer’s) and disrupts synaptic signaling. Some researchers have described Alzheimer’s disease as “Type 3 diabetes” to reflect the insulin resistance in brain tissue that characterizes the condition, though this characterization remains debated.

Even in people without diabetes, higher blood sugar levels within the normal range are associated with faster cognitive decline and higher dementia risk over long follow-up periods. This suggests that maintaining blood sugar toward the lower end of the normal range — not just below the diabetes threshold — may be relevant for long-term brain health, extending the importance of blood sugar management beyond the traditional framework of diabetes complications.

Taking Action on What You Know

Understanding why blood sugar matters is the beginning, not the end, of the conversation about metabolic health. The biochemical damage pathways described above can be slowed, stabilized, and in some cases partially reversed — but only with consistent, sustained action that keeps blood sugar as close to the normal range as possible over time. The tools available for this have never been better: continuous glucose monitoring allows people to see exactly how food, exercise, sleep, and stress affect their glucose levels in real time; newer medication classes offer glucose control with cardiovascular and kidney protection; and the evidence base for lifestyle interventions continues to grow stronger.

For people with prediabetes, acting now — before the damage accumulates and before the window for reversal begins to close — is by far the most cost-effective and health-preserving choice available. For people with diagnosed diabetes, optimal blood sugar management, combined with regular screening for early complications, is the most powerful tool available for preserving quality of life across all the systems described above. The connections are direct, the evidence is clear, and the stakes — a lifetime of vision, kidney function, nerve sensation, and heart health — are as high as they get.

Blood Sugar Variability: Beyond Average Levels

One insight that has emerged more clearly from continuous glucose monitoring research is that blood sugar variability — how much glucose fluctuates throughout the day — may matter for long-term health independently of the average level. Two people with the same average blood sugar (the same A1C) can have very different glucose profiles: one person may have relatively stable glucose, rarely spiking above 160 mg/dL, while another may swing from near-hypoglycemic lows to spikes above 200 mg/dL multiple times daily. Emerging evidence suggests that the high spikes and rapid drops in the more variable profile cause disproportionate oxidative stress and inflammatory activation compared to a more stable profile with the same average.

The mechanisms include the fact that oxidative stress increases steeply with glucose concentration — doubling blood sugar does not double oxidative stress, it multiplies it — so brief but high peaks generate more oxidative damage per minute than sustained moderate elevations. Rapid glucose drops after high peaks also trigger adrenaline responses and counter-regulatory hormone surges that independently stress the cardiovascular system. Reducing post-meal glucose spikes — through fiber-rich meal composition, post-meal walking, and careful carbohydrate selection — may therefore provide health benefits beyond what is captured by A1C measurement alone. For a detailed look at how different foods affect post-meal glucose, see our guide on blood sugar after meals.

Why Blood Sugar Matters Even Without a Diabetes Diagnosis

The evidence that blood sugar elevation damages health does not begin at the diabetes diagnostic threshold. It exists on a continuum, with risks rising progressively as blood sugar moves from the optimal range (fasting glucose below 85 mg/dL, A1C below 5.4%) through the normal range, into prediabetes, and into diabetes. This means that the question of why blood sugar matters is not only relevant for people with a diagnosis — it is relevant for any adult who is overweight, sedentary, poorly-sleeping, or eating a high-glycemic diet, because these factors elevate blood sugar within the “normal” range in ways that still have measurable long-term consequences.

Several large prospective studies have found that fasting blood sugar in the upper-normal range (90–99 mg/dL) is associated with meaningfully higher rates of cardiovascular events and dementia compared to fasting blood sugar in the lower-normal range (below 85 mg/dL) — differences that persist after adjusting for other risk factors. These findings do not mean that everyone with a fasting glucose of 92 mg/dL needs medication, but they do suggest that maintaining blood sugar toward the lower end of the normal range — through diet, exercise, adequate sleep, and stress management — is a worthwhile goal for anyone interested in long-term health and longevity, not just those with a formal metabolic diagnosis.

The foods that raise blood sugar most sharply — refined carbohydrates, added sugars, and sugar-sweetened beverages — are also independently associated with increased risk of metabolic syndrome, cardiovascular disease, and certain cancers through mechanisms that include, but go beyond, their blood sugar effects. A dietary pattern that supports stable blood glucose tends also to be rich in fiber, antioxidants, anti-inflammatory compounds, and micronutrients that benefit health through multiple pathways simultaneously. There is no meaningful tension between “eating for blood sugar” and eating for overall health — they point in the same direction.

Practical Monitoring: Knowing Your Numbers

Understanding why blood sugar matters leads naturally to the question of how to know where yours stands. The most accessible first step for any adult is a routine fasting blood glucose test and A1C test through their primary care provider, which together give a complete picture of current glucose status and three-month average. Adults at age 45 or older, or younger adults with risk factors (overweight, family history of diabetes, inactivity), should have these tests as a standard part of their preventive care — not only when symptoms appear.

For people who want a more dynamic picture of how their blood sugar responds to food, exercise, and daily life, over-the-counter blood glucose meters allow periodic self-monitoring, and continuous glucose monitors are becoming increasingly accessible for people without a diabetes diagnosis who want to understand their personal metabolic responses. Seeing how a specific meal, a night of poor sleep, a stressful workday, or a post-meal walk affects blood glucose in real time is one of the most powerful motivational tools available for making sustainable behavior changes — because it transforms blood sugar from an abstract health concept into immediate, personal, actionable data. For guidance on at-home monitoring tools and how to interpret the results, see our guide on home blood sugar monitoring.

Sources: American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S20–S42. • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977–986. • Luchsinger JA, Mayeux R. Adiposity and Alzheimer’s disease. Current Alzheimer Research. 2007;4(2):127–134.